Christopher Michael Finan (1977-2016) was born in Fort Campbell, Ky., the son of John and Janice (Baldery) Finan Jr. He earned a degree in Business Administration from the University of Saint Mary and married Eva Ellen Hanson in 2013. Chris is survived by his wife and his two-year-old daughter, Ellen Christine. He was a loving husband to Eva, an amazing father to Ellen, and a devoted friend. Chris...
John Costa was bold and passionate. He loved laughter, loved food, and most importantly, loved people. When he was diagnosed with kidney cancer, he told the doctors that he was going to beat it, and his story would be on their website. John stopped at nothing, traveling the country many times over to find the best and most aggressive treatment. He was also a generous man donating personally and ra...
During No Tie July, men are taking off their ties and donating to KCCure, but what can women do to show their support for kidney cancer research?
Chris Battle, who founded Security Debrief, died from kidney cancer in 2013, and today, we have an opportunity to pick up the fight where Chris left off.
KCCure President Dena Battle spoke (hilariously) with FamousDC about the organization, our cofounders and our month-long fundraising initiative, No Tie July.
Many thanks to FamousDC's Katherine Richardson for this great article about KCCure and our month-long fundraising effort, No Tie July!
Thanks to Politico for this great call-out on KCCure co-founder and President Dena Battle!
When it comes to kidney cancer, a tie isn’t good enough. We need a win. Join our fundraising effort, No Tie July, and help us raise life-saving research dollars. Here’s how you can participate.
Roll Call's Warren Rojas covered KCCure's story and our upcoming, month-long fundraising effort, No Tie July.
KCCure, the Kidney Cancer Research Alliance, was founded by three dedicated individuals who have each been personally impacted by kidney cancer.
Unleashing the immune system by inhibiting its natural breaks (i.e. immune checkpoints) has started an unprecedented revolution in kidney cancer immunotherapy treatment.